CAJO impose une péna
CAJO impose une pénalité de 30 000 $ à NorthStar Gaming (Ontario) Inc. TORONTO, 16 oct. 2024 (GLOBE NEWSWIRE) -- La Commission des alcools et des jeux de l’Ontario (CAJO) a délivré à NorthStar Gaming (Ontario) Inc. une ordonnance de sanction pécuniaire d’un montant...
AGCO_CoatofArms_blk.jpg
AGCO issues $30,000 penalty to NorthStar Gaming (Ontario) Inc.
16 oct. 2024 14h03 HE | Alcohol and Gaming Commission of Ontario
AGCO issues NorthStar Gaming (Ontario) Inc., a registered internet gaming operator, a $30,000 Order of Monetary Penalty
MNPR Triangle 2.JPG
Monopar and NorthStar Amend & Extend Collaboration
11 juin 2024 07h30 HE | Monopar Therapeutics Inc.
Highlights: Builds on Companies’ respective core strengthsAligns intellectual property rightsEstablishes a long-term supply agreement under which NorthStar provides actinium-225 for Monopar’s...
MNPR Triangle 2.JPG
Monopar and NorthStar Announce Expanded Radiopharma Program, Positive Preclinical Results, and Visibility Toward Human Trials
27 févr. 2023 07h00 HE | Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, Ill.) and NorthStar Medical Radioisotopes, LLC (Beloit, Wis.), today announced...
mono.jpg
Monopar and NorthStar Announce Filing of Composition of Matter Patent Protecting MNPR-101 Radiotherapeutic WILMETTE, Ill. and BELOIT, Wis., May 26, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
mono.jpg
Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery
24 mai 2021 08h00 HE | Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
monopar.jpg
Monopar and NorthStar Announce Selection of uPRIT Candidate for Potential Treatment of Severe COVID-19
10 déc. 2020 08h30 HE | Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, which are jointly developing a urokinase...
monopar.jpg
Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19
09 sept. 2020 08h30 HE | Monopar Therapeutics Inc.
WILMETTE, Ill., BELOIT, Wis. and TYLER, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, which are jointly developing...
monopar.jpg
Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19
19 août 2020 08h30 HE | Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis. and MORGAN HILL, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, IL) and NorthStar Medical Radioisotopes, LLC (Beloit,...
monopar.jpg
Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19
16 juin 2020 08h25 HE | Monopar Therapeutics Inc.
CHICAGO and BELOIT, Wis., June 16, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Chicago, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced today a 50/50...